© 2004 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© 2004 Oxford University Press
ARTICLE |
Effect on Tumor Cells of Blocking Survival Response to Glucose Deprivation
Affiliations of authors: Laboratory of Chemical Biology (HRP, YH, KS); Laboratory of Cell Growth and Regulation, Institute of Molecular and Cellular Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo, Japan (AT, YT, JY, TT); Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, Toshima-ku, Tokyo, Japan (SS, TY, TT)
Correspondence to: Kazuo Shin-ya, PhD, Laboratory of Chemical Biology, Institute of Molecular and Cellular Biosciences, The University of Tokyo, Bunkyo-ku, Tokyo 113-0032, Japan (e-mail: kshin{at}iam.u-tokyo.ac.jp) or Takashi Tsuruo, PhD, Laboratory of Cell Growth and Regulation, Institute of Molecular and Cellular Biosciences, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-0032, Japan (e-mail: ttsuruo{at}iam.u-tokyo.ac.jp)
Background: Glucose deprivation, a feature of poorly vascularized solid tumors, activates the unfolded protein response (UPR), a stress-signaling pathway, in tumor cells. We recently isolated a novel macrocyclic compound, versipelostatin (VST), that inhibits transcription from the promoter of GRP78, a gene that is activated as part of the UPR. We examined the effect of VST on the UPR induced by glucose deprivation or other stressors and on tumor growth in vivo. Methods: Human colon cancer HT-29, fibrosarcoma HT1080, and stomach cancer MKN74 cells were cultured in the absence of glucose or in the presence of glucose and a UPR-inducing chemical stressor (the N-glycosylation inhibitor tunicamycin, the calcium ionophore A23187, or the hypoglycemia-mimicking agent 2-deoxyglucose [2DG]). The effect of VST on UPR induction was determined by reverse transcription–polymerase chain reaction and immunoblot analysis of the UPR target genes GRP78 and GRP94; by immunoblot analysis of the UPR transcriptional activators ATF6, XBP1, and ATF4; and by analyzing reporter gene expression in cells transiently transfected with a GRP78 promoter–reporter gene. Cell sensitivity to VST was examined with a colony formation assay and flow cytometry. In vivo antitumor activity of VST was assessed with an MKN74 xenograft model. Results: VST inhibited expression of UPR target genes in glucose-deprived or 2DG-treated cells but not in cells treated with tunicamycin or A23187. VST also inhibited the production of the UPR transcriptional activators XBP1 and ATF4 during glucose deprivation. The UPR-inhibitory action of VST was seen only in conditions of glucose deprivation and caused selective and massive killing of the glucose-deprived cells. VST alone and in combination with cisplatin statistically significantly (P = .004 and P<.001 for comparisons with untreated control, respectively) inhibited tumor growth of MKN74 xenografts. Conclusion: Disruption of the UPR may provide a novel therapeutic approach to targeting glucose-deprived solid tumors.
CiteULike 
Connotea 
Del.icio.us What's this?
Editorial about this Article
- Versipelostatin: Unfolding an Unsweetened Death
- Edward A. Sausville
J Natl Cancer Inst 2004 96: 1266-1267.[Extract] [Full Text] [PDF]
This article has been cited by other articles:
|
|
 |
|
  J. J. Virrey, D. Dong, C. Stiles, J. B. Patterson, L. Pen, M. Ni, A. H. Schonthal, T. C. Chen, F. M. Hofman, and A. S. Lee Stress Chaperone GRP78/BiP Confers Chemoresistance to Tumor-Associated Endothelial Cells Mol. Cancer Res., August 1, 2008; 6(8): 1268 - 1275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Lange, J. C. Chavez, J. T. Pinto, G. Coppola, C.-W. Sun, T. M. Townes, D. H. Geschwind, and R. R. Ratan ATF4 is an oxidative stress-inducible, prodeath transcription factor in neurons in vitro and in vivo J. Exp. Med., May 12, 2008; 205(5): 1227 - 1242. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Yokouchi, N. Hiramatsu, K. Hayakawa, M. Okamura, S. Du, A. Kasai, Y. Takano, A. Shitamura, T. Shimada, J. Yao, et al. Involvement of Selective Reactive Oxygen Species Upstream of Proapoptotic Branches of Unfolded Protein Response J. Biol. Chem., February 15, 2008; 283(7): 4252 - 4260. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Dong, M. Ni, J. Li, S. Xiong, W. Ye, J. J. Virrey, C. Mao, R. Ye, M. Wang, L. Pen, et al. Critical Role of the Stress Chaperone GRP78/BiP in Tumor Proliferation, Survival, and Tumor Angiogenesis in Transgene-Induced Mammary Tumor Development Cancer Res., January 15, 2008; 68(2): 498 - 505. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Lefranc, V. Facchini, and R. Kiss Proautophagic Drugs: A Novel Means to Combat Apoptosis-Resistant Cancers, with a Special Emphasis on Glioblastomas Oncologist, December 1, 2007; 12(12): 1395 - 1403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Pyrko, A. H. Schonthal, F. M. Hofman, T. C. Chen, and A. S. Lee The Unfolded Protein Response Regulator GRP78/BiP as a Novel Target for Increasing Chemosensitivity in Malignant Gliomas Cancer Res., October 15, 2007; 67(20): 9809 - 9816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Tsukumo, A. Tomida, O. Kitahara, Y. Nakamura, S. Asada, K. Mori, and T. Tsuruo Nucleobindin 1 Controls the Unfolded Protein Response by Inhibiting ATF6 Activation J. Biol. Chem., October 5, 2007; 282(40): 29264 - 29272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Drogat, P. Auguste, D. T. Nguyen, M. Bouchecareilh, R. Pineau, J. Nalbantoglu, R. J. Kaufman, E. Chevet, A. Bikfalvi, and M. Moenner IRE1 Signaling Is Essential for Ischemia-Induced Vascular Endothelial Growth Factor-A Expression and Contributes to Angiogenesis and Tumor Growth In vivo Cancer Res., July 15, 2007; 67(14): 6700 - 6707. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. S. Lee GRP78 Induction in Cancer: Therapeutic and Prognostic Implications Cancer Res., April 15, 2007; 67(8): 3496 - 3499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Fu, J. Li, and A. S. Lee GRP78/BiP Inhibits Endoplasmic Reticulum BIK and Protects Human Breast Cancer Cells against Estrogen Starvation-Induced Apoptosis Cancer Res., April 15, 2007; 67(8): 3734 - 3740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Z. Yacoub Wasef, K. A. Robinson, M. N. Berkaw, and M. G. Buse Glucose, dexamethasone, and the unfolded protein response regulate TRB3 mRNA expression in 3T3-L1 adipocytes and L6 myotubes Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1274 - E1280. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. K. Misra, R. Deedwania, and S. V. Pizzo Activation and Cross-talk between Akt, NF-{kappa}B, and Unfolded Protein Response Signaling in 1-LN Prostate Cancer Cells Consequent to Ligation of Cell Surface-associated GRP78 J. Biol. Chem., May 12, 2006; 281(19): 13694 - 13707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. L. Rubenstein, J. Fridlyand, A. Shen, K. Aldape, D. Ginzinger, T. Batchelor, P. Treseler, M. Berger, M. McDermott, M. Prados, et al. Gene expression and angiotropism in primary CNS lymphoma Blood, May 1, 2006; 107(9): 3716 - 3723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. E. Feldman, V. Chauhan, and A. C. Koong The Unfolded Protein Response: A Novel Component of the Hypoxic Stress Response in Tumors Mol. Cancer Res., November 1, 2005; 3(11): 597 - 605. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. A. Sausville Versipelostatin: Unfolding an Unsweetened Death J Natl Cancer Inst, September 1, 2004; 96(17): 1266 - 1267. [Full Text] [PDF]
|
|